[Antiblastic effects of polycation polyhexamethyleneguanidine, a representative of a new class of antitumor drugs].
Lidak
M Iu
MIu
Baumanis
E A
EA
Zidermane
A A
AA
Kagan
T I
TI
Zakenfel'd
G K
GK
Lisianyĭ
N I
NI
Verovskiĭ
V N
VN
Birska
I A
IA
Zaletok
S P
SP
Bramberga
V M
VM
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011073:Polyamines; D000071228:Polyelectrolytes; D011108:Polymers; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013370:Subrenal Capsule Assay
D000970:Antineoplastic Agents; D006146:Guanidines; D011073:Polyamines; D000071228:Polyelectrolytes; D011108:Polymers; C060540:polyhexamethyleneguanidine
Ob antiblasticheskom deĭstvii polikationa poligeksametilenguanidina - predstavitelia novogo klassa protivoopukholevykh preparatov.